Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Completed · Phase 3

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to evaluate the efficacy and safety of an anti-allergy drug with a contact lens compared to placebo in preventing ocular itching associated with allergic conjunctivitis

Key facts

Study ID

NCT00445874

Run by

Vistakon Pharmaceuticals

People needed

120

Starts

2007-02-01

Expected to finish

2007-05-01

Last updated by the study team

2009-04-09

Who can join

Age: 8 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees withing the past 24 months
• Successful soft contact lens wearer who has frequently worn contact lenses for at least one month or more

You may not qualify if…

• Active ocular infection
• Clinically significant blepharitis
• Follicular conjunctivitis
• Pterygium
• Narrow angle glaucoma
• Dry eye dyndrome
• Ocular surgery within past 6 months
• Pregnancy or lactation

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Irvine, California, United States
• Study site — North Andover, Massachusetts, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Fairfield, Ohio, United States
• Study site — Mason, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.